Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-01

Clinical Trial Update: Efficacy and Safety of Telitacicept in IgAN [NA]

View source ↗

Summary

Clinical trial update on the efficacy and safety of Telitacicept for IgA nephropathy; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telitacicept

Snippet

Sponsor: Ruijin Hospital | Conditions: IgA Nephropathy (IgAN), Kidney Diseases | NA | Status: RECRUITING